精神运动性激越快速镇静药物疗效与安全性比较:系统综述与个体参与者数据网络Meta分析
该研究纳入18项随机试验(3411例参与者),采用个体参与者数据网络Meta分析比较急诊环境下快速镇静药物。重度激越时仅联合治疗优于氟哌啶醇。证据置信度极低,主要因不精确性和异质性。
要点
- 中度激越时抗精神病药-苯二氮䓬类联合、苯二氮䓬类及其他抗精神病药镇静效果均优于氟哌啶醇单药。
- 重度激越时仅抗精神病药-苯二氮䓬类联合优于氟哌啶醇,其余结果不确定。
- 氟哌啶醇单药锥体外系副作用风险更高,苯二氮䓬类单用或联用与低血压相关。
核心结论
- 抗精神病药-苯二氮䓬类联合可能是精神运动性激越快速镇静最有效的选择之一,但伴随低血压风险。
- 氟哌啶醇单药疗效较差且与锥体外系副作用相关。
- 证据置信度极低,需结合具体临床情境和患者特征解读。
研究设计与样本
- 系统综述与个体参与者数据网络Meta分析,检索多个数据库至2025年11月14日。
- 其中13项试验(2705例参与者)提供个体参与者数据,涉及抗精神病药、苯二氮䓬类及其联合。
- 采用贝叶斯一步随机效应个体参与者数据网络Meta回归,使用RoB 2评估偏倚风险,CINeMA评估证据置信度。
- 方案注册于PROSPERO(CRD42023402365),有 lived experience 人士参与设计和解读。
主要发现
- 氟哌啶醇单药与更高的锥体外系副作用风险相关;苯二氮䓬类单用或联用与低血压相关。
- 上述估计的置信度极低,主要由于不精确性和异质性。
关键数值与推荐
- 主要结局定义为15-30分钟内达到镇静。
- 证据置信度使用CINeMA框架评估,结果为极低。
临床怎么用
- 对于精神运动性激越患者,可考虑抗精神病药-苯二氮䓬类联合作为快速镇静选项,但需警惕低血压。
- 氟哌啶醇单药疗效较差且锥体外系副作用风险较高,应谨慎使用。
- 临床决策应结合具体医疗环境、患者特征及激越病因进行个体化选择。
- 目前证据不精确,需大规模试验提供更精确的推荐。
局限性
- 证据置信度极低,主要因不精确性和异质性。
- 仅13项试验提供个体参与者数据,部分药物比较数据有限。
- 结果需结合具体环境和患者特征解读,包括激越病因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several medications are available for rapid tranquilisation in psychomotor agitation, but choosing among them varies across local practices and this variation is compounded by inconsistent guidelines. We performed a systematic review with individual participant data network meta-analysis to inform evidence-based recommendations. METHODS: In this systematic review and individual participant data meta-analysis, we searched multiple databases from database inception to Nov 14, 2025, for randomised trials comparing intramuscular or intravenous treatments for rapid tranquilisation (primary outcome defined as sedation within 15-30 min) in patients with psychomotor agitation in general or psychiatric emergency settings. Anonymised individual participant data were collected and harmonised into a common dataset. Risk of bias was assessed using the RoB 2 tool. We performed Bayesian one-stage random-effects individual participant data network meta-regressions, accounting for between-study heterogeneity, drug classes, prognostic factors, and subgroup effects based on agitation severity. We combined individual participant data and aggregate data to evaluate side-effects. Confidence in the evidence was assessed using the Confidence In Network Meta Analysis (CINeMA) framework. People with lived experience were involved in the design and interpretation of the findings. The protocol was registered with PROSPERO (CRD42023402365). FINDINGS: We included 18 trials across eight regions (3411 participants; 1988 [58·3%] men, 1423 [41·7%] women; mean age 36·0 [SD 11·7] years), of which 13 trials (2705 participants) provided individual participant data for antipsychotics, benzodiazepines, and their combination. In moderate agitation, odds of achieving sedation relative to haloperidol monotherapy were higher with antipsychotic-benzodiazepine combinations (odds ratio [OR] 12·93, 95% credible interval [95% CrI] 3·00-50·91; relative risk [RR] 1·58), benzodiazepines (5·52, 1·37-21·02; 1·49), and other antipsychotics (4·54, 1·35-14·45; 1·45). In severe agitation, antipsychotic-benzodiazepine combinations were more effective than haloperidol (4·86, 1·28-17·54; 1·73), whereas results were uncertain for benzodiazepines (2·09, 0·58-6·99; 1·38) and other antipsychotics (1·70, 0·62-4·59; 1·28). Confidence in these estimates was very low, mainly due to imprecision and heterogeneity. Haloperidol monotherapy was associated with higher risk of extrapyramidal side-effects and benzodiazepines, alone or in combination, with hypotension. INTERPRETATION: Antipsychotic-benzodiazepine combinations might be among the most effective options for rapid tranquilisation in patients with psychomotor agitation but carry a risk of hypotension, whereas haloperidol monotherapy appeared among the least effective and is associated with extrapyramidal side-effects. These findings should be contextualised to the specific setting and patient characteristics, including the underlying agitation aetiology. Large trials are needed to provide more precise recommendations. FUNDING: German Ministry of Research, Technology and Space and Swiss National Science Foundation.
引用
- Siafis S, Philipona F, Nomura N, et al. Comparative effectiveness and safety of pharmacological treatments for rapid tranquilisation in emergency settings: a systematic review and individual participant data network meta-analysis. Lancet Psychiatry. 2026. PMID: 42259329. doi:10.1016/S2215-0366(26)00097-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。